BioSpace News Archive

Sanofi and GSK announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta vaccine candidate.

Burning Rock Biotech Limited announced the resignation of Mr. Jing Rong as a director from the Board, and the appointment of Dr. Licen Lisa Xu as an independent director to the Board.

Versantis announced data showing both single and repeated intraperitoneal administrations of VS-01 reduced the concentration of several metabolites in the blood associated with infection-related acute-on-chronic liver failure and multiple organ failure related to ACLF.

Emergent BioSolutions Inc. announced that the U.S. Food and Drug Administration accepted for review the Biologics License Application for AV7909.

Can-Fite BioPharma Ltd. today announced its study titled “A3 adenosine receptor allosteric modulator CF602 reverses erectile dysfunction in a diabetic rat model” was published in the peer-reviewed journal Andrologia.

Eton sold its rights in Biorphen®, Rezipres®, and Cysteine Hydrochloride products for total payments of up to $50 million.

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced the upcoming presentation of new and important clinical data for its AAVS3-based gene therapy candidate FLT180a at the International Society on Thrombosis and Haemostasis (ISTH) Congress to be held in London, July 9-13, 2022.

Stryker, a leading medical technologies company, attended the 6th World Intelligence Congress in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market.

Forecast to 2030,’ thoroughly examines the Ferric Citrate industry to provide essential data & information for the targeted readers.

Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the completion of the phase 3 clinical trial investigating emixustat hydrochloride (“emixustat”) in patients with macular atrophy secondary to Stargardt disease.